๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resistance

โœ Scribed by Anna Ludovica Fracanzani; Luca Valenti; Silvia Fargion


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
40 KB
Volume
48
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


Children and adolescents with normal ALT levels differed significantly from those with abnormal aminotransferases in waist circumference (P ฯญ 0.05), triglycerides (P ฯญ 0.05), 2-hour glucose (P ฯญ 0.004), and insulin (P ฯญ 0.01) after a standard load of 75 g glucose. On univariate analysis, in the group of children with normal ALT levels, age (P ฯญ 0.04), impaired glucose metabolism (defined as yes/no including impaired fasting or glucose tolerance and overt type 2 diabetes [P ฯญ 0.05]), and 2-hour glucose (P ฯญ 0.02) associated significantly with nonalcoholic steatohepatitis. Insulin resistance (as estimated by the Homeostatic Model Assessment [HOMA-IR]) was associated with fibrosis (grade ี†2 [P ฯญ 0.04]). In patients with abnormal ALT levels, no variable associated significantly with nonalcoholic steatohepatitis, and ALT was the only variable associated with fibrosis (P ฯฝ 0.0001). The model variables included age, body mass index, ALT, HOMA-IR, 2-hour glucose and insulin, and presence of glucose metabolism abnormalities (as described above).

In conclusion, there is a strong agreement between data obtained in Italian adult patients with those of children. In agreement with the report of Fracanzani et al., 1 we found a prevalence of necro-inflammation and fibrosis in children with ultrasonographic evidence of steatosis even in absence of ALT abnormalities; in this group of individuals, impaired glucose metabolism and insulin resistance are the factors more closely associated with severe liver disease. The prevalence and the number of the components of the MetS is similar between patients with normal and abnormal ALT values. Therefore, in children as well as in adults, normal ALT does not represent a valuable criterion to exclude from liver biopsy patients with persistently ultrasonographic evidence of steatosis. Because the disease may persist into adulthood and the lifestyle intervention may result in the significant amelioration of histological derangement, 4 there is a strong need for identifying individuals among those presenting with risk factors for NAFLD (obesity, insulin resistance, and so forth) at risk for severe histological liver derangement despite normal ALT values.


๐Ÿ“œ SIMILAR VOLUMES


Risk of severe liver disease in nonalcoh
โœ Anna Ludovica Fracanzani; Luca Valenti; Elisabetta Bugianesi; Marco Andreoletti; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB

It is uncertain whether patients with nonalcoholic fatty liver disease (NAFLD) and normal alanine aminotransferase (ALT) have a milder disease and should undergo liver biopsy. We reviewed the histological data of 458 Italian patients with NAFLD in whom liver biopsy was indicated by altered liver enz

Insulin resistance links nonalcoholic fa
โœ Federico Salamone; Fabio Galvano; Giovanni Li Volti ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 296 KB ๐Ÿ‘ 1 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

In vivo assessment of liver cell apoptos
โœ Anna Wieckowska; Nizar N. Zein; Lisa M. Yerian; A. Rocio Lopez; Arthur J. McCull ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 344 KB ๐Ÿ‘ 1 views

In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only reliable way to differentiate simple steatosis from nonalcoholic steatohepatitis (NASH). Noninvasive methods are urgently needed. Increasing evidence suggests hepatocyte apoptosis is a key mediator of liver in